Protocol Summary

Protocol No.: OCR15562

Sponsor Protocol No.: TARGET-HCC

Study Title
A 5-year Longitudinal Observational Study of the Natural History and Management of Patients with Hepatocellular Carcinoma

Principal Investigator(s)
Cabrera, Roniel

Objective
TARGET-HCC is a longitudinal, observational study of patients being managed for HCC in usual clinical practice. TARGET-HCC will create a research registry of participants with HCC within academic and community real-world practices in order to assess the safety and effectiveness of the entire spectrum of current and future therapies across diverse populations.

Phase: NA

Age Group: Adult

Scope: National

Detailed Eligibility
INCLUSION CRITERIA:
1. Ages 18 years old and older
2. Patients with a histological/cytological or radiological diagnosis of HCC (mixed HCC cholangiocarcinoma may be included; patients who are candidates for surgical and non-surgical treatment, as well as those being followed without specific HCC therapy may be included)

EXCLUSION CRITERIA:
1. Inability to provide written informed consent

Applicable Disease Sites
Liver Cancer

Participating Institutions
UF Gainesville : Patrick Horne

Contact
Patrick Horne
Phone: +1 352-273-9464

Email: patrick.horne@medicine.ufl.edu

More Information:
View study listing on ClinicialTrials.gov
http://www.clinicaltrials.gov/ct2/show/
NCT02954094